Last updated: August 1, 2019
Sponsor: MASONIC CANCER CENTER UNIVERSITY OF MINNESOTA
Overall Status: Completed
Phase
2
Condition
Leukemia
Cancer/tumors
Chronic Myeloid Leukemia
Treatment
N/AClinical Study ID
NCT00303693
Ages 1-70 Both
Study Design
Total Participants: 100
Study Start date:
January 01, 2004
Estimated Completion Date:
November 21, 2017